Article Text
Abstract
Background The clinical consequences and factors related to the progression from a carotid near-occlusion (CNO) to a complete occlusion are not well established. Our aim is to describe the rate, predictive factors and clinical implications of the progression to complete carotid occlusion (PCCO) in a population of patients with symptomatic CNO.
Methods We conducted a multicenter, nationwide, prospective study from January 2010 to May 2016. Patients with angiography-confirmed CNO were included. We collected information on demographic data, clinical manifestations, radiological and hemodynamic findings, and treatment modalities. A 24 month carotid-imaging follow-up of the CNO was performed.
Results 141 patients were included in the study, and carotid-imaging follow-up was performed in 122 patients. PCCO occurred in 40 patients (32.8%), and was more frequent in medically-treated patients (34 out of 61; 55.7%) compared with patients treated with revascularization (6 out of 61; 9.8%) (p<0.001). 7 of the 40 patients with PCCO (17.5%) suffered ipsilateral symptoms. Factors independently related with PCCO in the multivariate analysis were: age ≥75 years (OR 2.93, 95% CI 1.05 to 8.13), revascularization (OR 0.07, 95% CI 0.02 to 0.20), and collateral circulation through the ipsilateral ophthalmic artery (OR 3.25, 95% CI 1.01 to 10.48).
Conclusions PCCO occurred within 24 months in more than half of the patients under medical treatment. Most episodes of PCCO were not associated with ipsilateral symptoms. Revascularization reduces the risk of PCCO.
- stroke
Statistics from Altmetric.com
Footnotes
Twitter @angarpas1
Contributors AG-P: study concept and design, acquisition of data, analysis and interpretation, preparation of the manuscript, and study supervision. AG-N: study concept and design, analysis and interpretation, critical revision of the manuscript for important intellectual content, and study supervision. JMRM, NG-N, JT, FM, JCP-C, PM-S, BF, MÁG-G, MAdL, JM, DC-V, YA, VP, AL-M, AMdA-B, MU-R, RD-M, AP, ÁX-C, MB-I, EC-R: acquisition of data and critical revision of the manuscript for important intellectual content.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval This study obtained ethics approval from “Comité de Ética e investigación Clínica Hospital General Universitario Gregorio Marañón”, with ID number of the approval: 122/09. Participants gave informed consent before taking part in the study.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available upon reasonable request